Our Rashomon Moment
State Legislatures Lead the Way on Policy Reform to Protect Personalized Medicine
The Role of Specialty Pharmacies in Improving Prescription Drug Access and Affordability for Consumers
Managed Care & Clinical Updates: February 2023
Recent FDA Actions: February 2023
From Our Partners: February 2023
News from our Strategic Alliance Partners.
Finding Quality in Cancer Care Beyond the Hospital Walls
Coverage from the January 18, 2023, Institute for Value-Based Medicine session with Regional Cancer Care Associates held in New Brunswick, New Jersey.
Tennessee Oncology’s Richard L. Martin III, MD, MPH: “Equity Cannot Be Just Something We Do for a Single Day”
Richard L. Martin III, MD, MPH, medical director for Health Equity and Community Engagement, Tennessee Oncology; president, Tennessee Oncology Practice Society.
Center on Health Equity & Access: February 2023
New Century Health’s Andrew Hertler, MD, FACP: “You Have to Be Careful When You Look at Total Cost of Care”
Practices Need More Proactive Approaches to Influence Evolving Oncology Ecosystem
Kashyap Patel, MD, Reflects on Progress in Addressing Disparities in Cancer Care
To Expand Access to Cancer Expertise, Collaboration Is Key
Zanidatamab, With Biparatopic Binding to HER2, Shows 84% OS in Phase 2 Study of Gastroesophageal Adenocarcinoma
The investigational therapy promises a new way to target HER2 while still using chemotherapy combinations.
NCCN Guideline Update Reflects Rise of Precision Options in NSCLC
The latest updates in non–small cell lung cancer (NSCLC) cover recommendations for diagnostics, staging, when to use biomarker testing, sequencing of therapeutic options, and the addition of new treatments.
